PLYX

4.54

11.33% -0.58

Vorhandelsmarkt: 4.62 0.08 +1.76%

Polaryx Therapeutics Inc (PLYX)

Überblick Nachrichten Preisverlauf Forum Prognose

Schlusskurs vom Vortag:

$5.12

Offen:

$5.175

24-Stunden-Volumen:

129.27K

Relative Volume:

0.08

Marktkapitalisierung:

$214.94M

Einnahmen:

Nettoeinkommen (Verlust:

$-8.99M

KGV:

-23.92

EPS:

-0.1898

Netto-Cashflow:

$-3.94M

1W Leistung:

-19.36%

1M Leistung:

-36.41%

6M Leistung:

+0.00%

1J Leistung:

+0.00%

1-Tages-Spanne:

$4.53

$5.175

1-Wochen-Bereich:

$4.53

$5.63

52-Wochen-Spanne:

$2.201

$33.90

Polaryx Therapeutics Inc Stock (PLYX) Company Profile

Firmenname

Polaryx Therapeutics Inc

Sektor

Healthcare (1106)

Branche

Biotechnology (615)

Telefon

201-940-7236

Adresse

140 EAST RIDGEWOOD AVENUE, PARAMUS

Mitarbeiter

Twitter

Nächster Verdiensttermin

null

Neueste SEC-Einreichungen

PLYX's Discussions on Twitter

Compare PLYX vs VRTX, REGN, ARGX, ALNY, ONC

Aktien	Preis	Marktkapitalisierung	Umsatz	Nettogewinn	Free Cashflow	ENV
PLYX Polaryx Therapeutics Inc	4.54	214.94M	0	-8.99M	-3.94M	-0.1898
VRTX Vertex Pharmaceuticals Inc	424.36	107.87B	12.32B	4.34B	3.19B	16.86
REGN Regeneron Pharmaceuticals Inc	702.27	73.63B	14.92B	4.42B	3.79B	41.04
ARGX Argen X Se Adr	794.70	49.42B	4.16B	1.29B	734.26M	19.58
ALNY Alnylam Pharmaceuticals Inc	301.11	40.20B	3.71B	313.75M	465.38M	2.2571
ONC Beone Medicines Ltd Adr	297.49	33.06B	5.36B	287.73M	924.18M	2.5229

Polaryx Therapeutics Inc Stock (PLYX) Upgrades & Downgrades

Datum	Aktion	Analytiker	Ratingänderung
2026-02-27	Eingeleitet	Maxim Group	Buy

Polaryx Therapeutics Inc Aktie (PLYX) Neueste Nachrichten

Apr 28, 2026

Polaryx Therapeutics, Inc. Financial Disclosures & SEC Filings - TradingView

Apr 28, 2026

Apr 27, 2026

PLYX Technical Analysis | Trend, Signals & Chart Patterns | POLARYX THERAPEUTICS INC (NASDAQ:PLYX) - ChartMill

Apr 27, 2026

Apr 25, 2026

Technical Analysis of Polaryx Therapeutics, Inc. (NASDAQ:PLYX) - TradingView

Apr 25, 2026

Apr 24, 2026

PLYX Polaryx Therapeutics highlights rare disease pipeline progress in its newly released quarterly earnings report.Verified Stock Signals - Newser

Apr 24, 2026

Apr 23, 2026

Polaryx Therapeutics to Participate in National Tay-Sachs & Allied Diseases Association Annual Family Conference - The Manila Times

Apr 23, 2026

Polaryx heads to Tay-Sachs family meeting with Phase 2 program - Stock Titan

Apr 23, 2026

Apr 22, 2026

FDA grants fast track status to Polaryx’s PLX-200 for three rare diseases - Investing.com Nigeria

Apr 22, 2026

Apr 21, 2026

Polaryx receives U.S. FDA Fast Track Designation for PLX-200 - TipRanks

Apr 21, 2026

Polaryx Therapeutics Gets FDA Fast Track Designations for Its Lead Drug Candidate - marketscreener.com

Apr 21, 2026

Polaryx Therapeutics receives U.S. FDA fast track designations for all four indications to be evaluated in the Soteria Basket Trial - marketscreener.com

Apr 21, 2026

Polaryx Therapeutics Receives U.S. FDA Fast Track Designations for All Four Indications to be Evaluated in the SOTERIA Basket Trial - The Manila Times

Apr 21, 2026

FDA fast-tracks Polaryx drug for 4 rare childhood disorders - Stock Titan

Apr 21, 2026

Apr 20, 2026

Does Polaryx Therapeutics (PLYX) Stock Pay Dividends? (Underperforming) 2026-04-20Real Trader Network - Cổng thông tin điện tử Tỉnh Sơn La

Apr 20, 2026

Apr 17, 2026

PLYX Should I Buy - Intellectia AI

Apr 17, 2026

Apr 15, 2026

Polaryx Therapeutics Recognized with Pinnacle Award for Excellence in Pediatric Care - The Manila Times

Apr 15, 2026

A rare-disease biotech, Polaryx, just won a pediatric care award - Stock Titan

Apr 15, 2026

Apr 14, 2026

Number of employees of Polaryx Therapeutics, Inc. – NASDAQ:PLYX - TradingView

Apr 14, 2026

Apr 10, 2026

What makes Polaryx Therapeutics (PLYX) Stock attractive or not | Price at $5.63, Down 2.26%Shared Buy Zones - Newser

Apr 10, 2026

Apr 09, 2026